Therefore, the inflammatory milieu of CLL with the elevated levels of IL-18, IL-12, IL-15, and Gal-9 that are released from CLL cells might explain a mechanism that results in the reduction of CD26highCD8+ T cells pool in CLL (Fig. 7B). This evidence concerns the gene IL18 and B-cell chronic lymphocytic leukemia.